Patents by Inventor JEROME POUPIOT

JEROME POUPIOT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENE THERAPY EXPRESSION SYSTEM ALLOWING AN ADEQUATE EXPRESSION IN THE MUSCLES AND IN THE HEART OF SGCG
    Publication number: 20230256117
    Abstract: The present invention concerns an expression system for systemic administration comprising a sequence encoding gamma-sarcoglycan (SGCG) placed under the control of a promoter allowing an adequate expression of SGCG in the skeletal muscles and in the heart, and its use for the treatment of Limb-Girdle Muscular Dystrophy type C.
    Type: Application
    Filed: June 18, 2021
    Publication date: August 17, 2023
    Inventors: Isabelle RICHARD, Jerome POUPIOT
  • Methods for diagnosing or monitoring muscular dystrophies
    Patent number: 11099193
    Abstract: The invention relates to a method for prognosing, diagnosing, determining the risk, and monitoring the evolution of a muscular dystrophy. It also relates to a method for evaluating the efficacy of a treatment of a muscular dystrophy in a subject in need thereof.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: August 24, 2021
    Assignee: GENETHON
    Inventors: Jeremy Rouillon, Fedor Svinartchouk, Jerome Poupiot, Isabelle Richard
  • METHODS FOR DIAGNOSING OR MONITORING MUSCULAR DYSTROPHIES
    Publication number: 20160334417
    Abstract: The invention relates to a method for prognosing, diagnosing, determining the risk, and monitoring the evolution of a muscular dystrophy. It also relates to a method for evaluating the efficacy of a treatment of a muscular dystrophy in a subject in need thereof.
    Type: Application
    Filed: January 9, 2015
    Publication date: November 17, 2016
    Inventors: JEREMY ROUILLON, FEDOR SVINARTCHOUK, JEROME POUPIOT, ISABELLE RICHARD